There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Clinical trials of prophylactic implantable cardioverter-defibrillators (ICDs) have included a minority of patients with a left ventricular ejection fraction (LVEF) between 30% and 35%. Because a large number of ICDs in the United States are implanted in such patients, it is important to study survival associated with this therapy.

Related collections

Author and article information

Journal

PubMed ID:: 24893088

PMC ID:: 4122230

DOI:: 10.1001/jama.2014.5310

Data availability:

Comments

Comment on this article

scite_

Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%.

Read this article at

JAMA Network: Coronavirus

Journal

Comment on this article